AleAnna Total Assets 2022-2024 | ANNA

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

AleAnna total assets from 2022 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

AleAnna total assets from 2022 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.

Related Stocks
Company Name	Market Cap
Zoetis (ZTS)	$73.2B
Chugai Pharmaceutical (CHGCY)	$73B
Takeda Pharmaceutical (TAK)	$41.9B
Merck (MKKGY)	$18.4B
Sandoz Group AG (SDZNY)	$18B
Astellas Pharma (ALPMY)	$17.5B
United Therapeutics (UTHR)	$16B
Neurocrine Biosciences (NBIX)	$13.9B
Summit Therapeutics (SMMT)	$13.2B
Shionogi (SGIOY)	$11.9B
Madrigal Pharmaceuticals (MDGL)	$6.8B
Orion OYJ (ORINY)	$6.2B
Ionis Pharmaceuticals (IONS)	$5.5B
Corcept Therapeutics (CORT)	$5.3B
Crinetics Pharmaceuticals (CRNX)	$4.7B
PTC Therapeutics (PTCT)	$3.5B
Recursion Pharmaceuticals (RXRX)	$2.6B
Catalyst Pharmaceuticals (CPRX)	$2.5B
AMNEAL PHARMACEUTICALS, INC (AMRX)	$2.4B
Dyne Therapeutics (DYN)	$2.4B
NewAmsterdam Pharma (NAMS)	$2.4B
Centessa Pharmaceuticals (CNTA)	$2.2B
Soleno Therapeutics (SLNO)	$2B
Indivior (INDV)	$1.7B
Xencor (XNCR)	$1.7B
BioCryst Pharmaceuticals (BCRX)	$1.6B
Evotec AG (EVO)	$1.5B
Aurinia Pharmaceuticals Inc (AUPH)	$1.3B
Ocular Therapeutix (OCUL)	$1.3B
Guardian Pharmacy Services (GRDN)	$1.3B